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Le deftpour les activistes du VIH Isida et
contre le sexisme est de prioriser le
traitement pour les ftmmes dans les
projets des chercheurEs, des soignantEs,
des organisations contre le sida, dans le
but dameliorer les connaissances et
d'offrir de meilleurs services. Cet arti-
cle est une version abrigee d'une recher-
che pour la Campagne Action
Traitement en Aftique du Sud.
The gender politics of HIV/AlDS has
been mainly focused on prevention,
particularly on women's vulnerabil-
ity to HIV infection and the preven-
tion ofmother-to-child transmission,
and seldom on women's care issues
of which treatment is a vital part.
Gender inequality is reflected in the
response to HIV/AIDS. One of the key
responses to women and HIV/AIDS
has been to highlight women's re-
productive role and to focus on the
prevention ofmother-to-child trans-
mission. Women want, and have a
right to, reproductive health services
that will increase the likelihood of
healthy babies. However, women are
often seen only as mothers and not as
individuals in their own right, with
their own identities and needs.
There is a vast body of literature,
about the treatment and manage-
ment ofHIV/ AIDS. The problem with
much of this research is male bias-
it is defined and conducted by men
with most of the research partici-
pants being men (Doyal). It also pays
little or no attention to the different
manifestations of HIV in men and
women. Whilst much of the infor-
mation available is relevant for both
men and women living with HIV/
AIDS, the failure to address differ-
ences impacts negatively on wom-
en's health and well-being.












A Contextual Analysis of Women
and Health
A gendered approach to health
does not only include biological fac-
tors but also considers the critical
roles that social and cultural factors
play in promoting, protecting, or
impeding health (Garcia-Moreno
1999). Power relations between
women and men, and between
health-care provider and client, are
informed by these social and cultural
factors. In short, biological and so-
cial factors must be analyzed to un-
derstand how women and men expe-
rience health and illness.
The macro-political and economic
factors that impact on health in gen-
eral, and women's health, in particu-
lar, are located at both a national and
global level. At a national level, the
fiscal policies of governments mean
that political choices are made which
are often not in favour of the poor,
particularly poor women, and one of
the first areas to be impacted upon is
that of health. To an increasing ex-
tent, pressures that arise out of the
global economy influence national
government decision-making. The
political and economic factors that
impact on women's health include
globalization of trade and finance
and huge debt repayments that di-
vert funds from social services.
The imposition of structural ad-
justment programs on indebted
countries by the World Bank and
International Monetary Fund (IMF)
force governments to apply cutbacks
to social services such as education
and health. This adjustment impacts
on women, men, and children in
indebted countries. "Silent adjust-
ment" is a term that has been coined
to reflect the undue hardship and
pressure that women experience as a
result of structural adjustment.
Socio-economic factors that also
impact on the health of men and
women include poverry, migration
and mobility, rate of urbanization,
levels of violence, education, and
access to healthcare amongst others.
Despite many gains made by
women in the last 40 years, gender
equality is not yet a reality for many
women. Women still lack economic,
political, and social power. Wom-
en's relationships with men are char-
acterized by unequal power dynam-
ics. Socially-defined roles for men
and women see women's main role
as reproductive, which includes child-
bearing and care for children and the
family. May refers to the "time pov-
erty" ofwomen which is the result of
the long hours women spend on
their reproductive roles-collecting
fire-wood and water, caring for chil-
dren, cooking and cleaning-to the
detriment of their own well-being.
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The South Mrican Constitution en-
trenches women's equality, however,
this does not necessarily translate to
equality in women's lives, and in
reality, little has changed for most
women.
Women are more likely to be poor
and malnourished and are less likely
to have access to services-health,
sanitation, clean water, education-
and formal sector employment
(Todaro). Female-headed house-
holds in South Mrica are generally
poorer than male-headed households.
In 1995, the average annual income
of households headed by men was
$48,000 ($12,000 CON) compared
to only $25,000 ($6,250 CDN) for
women-headed households. (Hurt
and Budlender).
Even when women have access to
income and assets (including land,
equipment, employment, knowl-
edge, and skills), these are often con-
trolled by men and women are less
able to get out of the poverty trap
(May).
Gender Inequalities in Health
Gender inequality impacts on
every aspect of health and illness.
This includes differences in vulner-
ability to illness and disease, preven-
tion, the response of the individual
to their symptoms, organization and
delivery ofhealth care, the politics of
diagnosis, questions asked by clini-
cal researchers, the knowledge and
understanding of disease, and the
treatment required (Lorber).
Women are more vulnerable to
HIV infection than men, partly due to
physiology but also partly due to
their limited ability to protect them-
selves from infection. This is height-
ened by a lack ofwomen-controlled
barrier mechanisms and socially con-
structed "rules" of heterosexual sex,
where men have the power to decide
when, where, and howsex takes place.
We know relatively little about HIV/
AIDS in women, even less so in devel-
oping countries and this obviously
impacts on treatment issues (Patton;
Johnson; Bass; MacNeill).
Gender Bias in Medical Research
Medical research is a profoundly
gendered activity that is determined
from a male perspective. Common
problems experienced by women re-
ceive little attention if they are not
seen as part ofwomen's reproductive











gree of exposure and also the access
and control of resources needed to
protect women and men from infec-
tion. In diseases that affect both men
and women many researchers have
ignored possible differences in diag-
nostic indicators, in symptoms, in
prognosis, and in the relative effec-
tiveness of different treatments
(Garcia-Moreno; Doyal; Foster).
Women's exclusion in research is
justified on the grounds that cyclical
hormonal changes make it difficult
to interpret results and/or the fact
that women may become pregnant
and put the fetus at risk. Yet, "results
obtained from research on predomi-
nately male subjects are applied with
little question to (potentially) preg-
nant women patients" (Garcia-
Moreno 19).
On a global scale, in both a devel-
oped and developing context, there
is a lack of attention of health issues
for women who are poor. Studies
carried out on households in various
countries show that less is spent on
health care for women and girls
(Garcia-Moreno). Female headcd-
households spend more income on
the nutritional needs of the house-
hold's members (Posel). According
to May, if consumption patterns in
male headed-households were to
mirror those inwomen headed house-
holds, the incidence ofunder-nutri-
tion in South Mrica would fall by
twelve per cent (cited in Posel).
Women are more likely to put the
health care needs ofothers, such as a
partner or children before their own
needs (Garcia-Moren; Koblinsky,
Timyan, and Gay). The health-seek-
ing behaviour of women is mainly
based on their reproductive role-
either as a pregnant woman or as a
mother with a sick child-and is
usually what brings women into the
health care arena. Other factors that
impact on women's health-seeking
behaviour include time, mobility,
access to fundslresources, fear of
health care proViders/facilities, and
other social constraints which dis-
courage women from attending
healthcare facilities (Garcia-Morena;
Koblinsky et al.; Miles).
Gender dimensions of health can
be causal factors in limiting the qual-
ity ofcare women receive. The qual-
ity of care received is often depend-
ent on the power dynamic between
the health care provider and patient/
client. Women's subjective experi-
ences ofmedical encounters include
sexism of doctors, and biases inher-
ent in the institution of medicine,
which can make the experiences de-
meaning for women. Within repro-
ductive health services, health care
providers focus on controllingwom-
en's fertility. This is characterized by
a failure to communicate informa-
tion and a lack ofcultural sensitivity.
This often results in dehumanizing
treatment that may affect women's
willingness to use the services.
Strategies to improve women's
health need to be grounded in a
rigorous analysis of the whole range
of women's productive and repro-
ductive activities and the way these
change across their life span.
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Issues for Women Living with
HW/AIDS
In the final analysis the combi-
nation ofunequal access to care
and the gender gap in medical
knowledge contributes to asitu-
ation where women in both rich
and poor countries have ashorter
expectancy than men after a di-
agnosis ofAIDS. (Garcia-Moreno
14)
Only in 1993 did the Centers for
Disease Control (CDC) extend the list
of defining HIV related illnesses to
include gynecological abnormalities
and cancers. A5 Patton notes,
women were continuallywithin
epidemiologists line of vision,
but it took a decade to achieve
official recognition of the
uniqueness of their clinical and
social experience of the epi-
demic. (13)
The response to HIV/AlDS must
concentrate on all aspects of the pre-
vention/care continuum. In South
Africa, the main focus ofthe HIV/AIDS
response has been on prevention. In
relation to care there has been a focus
on home and community-based care
as a solution to an over-burdened
health care system. Treatment issues
for women have largely focused on
the prevention of mother-to-child
transmission. While this is a vital
intervention, which impacts on a
women's psychologically and emo-
tionally, it is not a treatment issue for
women. It is vital for women to be
seen as separate from their reproduc-
tive roles and for research and serv-
ices to be extended to meet all of
women's treatment needs.
A review of the literature high-
lights the following key problem ar-
eas to be addressed with regard to
treatment issues for women:
-Are there differences in how HIV
manifests in men and women? (For
example, differences and similarities
in opportunistic infections, meas-
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urements of viral load! and cD+4
counts, and life span.)
-Given that initial findings sug-
gest that differences exist in both
type and severity of opportunistic
infections as well as in viral load-
what, then, are the implications for
dosage and timing of treatment,
"Unequal access







than men after a
diagnosis of AIDS."
clinical management and "positive
living."
Much has been written about
women with HIV/AlDS dying earlier
than men with HIV/AIDS (Anderson).
There is nothing inherent in women
that make this the case. Rather, fac-
tors such as access to health care, pro-
active health-seeking behaviour, and
self-management of the disease im-
pact on the life span ofa person with
HIV/AIDS. Ithas previously been men-
tioned that women have less access
to health care than men do and are
more likely to prioritize the health
needs ofothers. This necessarily im-
pacts on the course ofthe disease and
their life span (Marks).
The exclusion of women from
many research studies prolongs the
male bias in research. Johnson states
that women still comprise only about
twelve per cent of the total partici-
pants in clinical trails. Key questions
regarding the biological differences
in female and male experiences in
AIDS remains unanswered. 11i,i af-
fects women getting an accurate di-
agnosis and treatment.
Some Treatment Issues
There are three basic purposes for
treatments available for people living
with HIV:
-Treatments used to prevent op-
portunistic infections (prophylaxis)
and drugs to treat opportunistic in-
fections;
-Treatments used against the vi-
rus itself (anti-retrovirals);
-Treatments used to relieve or
eliminate symptoms associated with
HIV and the side effects ofother treat-
ments (McCullum).
Differences in Viral load, cD4
Count and Disease Progression
In the field of AIDS we still have
only hints about differences in
dosing, clues of metabolic dif-
ferences and suggestions ofwhat
viral load levels could mean in
terms of HIV progression In
women. (MacNeil 14)
HIV positive women may have a
higher risk of progressing to AIDS
than men with the same viral load
(MacNeil). This finding was based
on a study of drug injecting women
and men and means that women
living with HIV who inject drugs can
develop AIDS with less virus than posi-
tive men who inject drugs. Based on
the results of the study, questions
were raised about whether the initia-
tion of anti-HIV therapy at a lower
viral threshold may be justified. The
study recommended that viral load
should be considered to be a gender
variable (Mitchell 1999).
In Januaty 2000, a meeting of
scientists and treatment activists was
held in the United States to discuss
and debate the issue ofgender differ-
ences in treatment. The following
points, based on research to date
were highlighted:
·Women may have lowervirallev-
els than men in early HIV disease (in
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the first five years of infection);
oDifferences may not persist over
time-the cause and significance of
the differences remains unclear;
oNo changes have been recom-
mended for the use of anti-HIV
therapy among women;
oRacial and ethnicity differences
in viral load may be equally impor-
tant to gender differences and should
be explored (Project Inform 2000).
Combination therapies and anti-
retrovirals
The decision to begin combina-
tion therapy is made on viral load,
damage done to immune system
(co4+ count), and the ability to keep
up the treatments on a regular basis
for life. The response of women to
drug therapies is the area where most
information is needed. There are too
few women enrolled in
clinical trails to deter-
mine whether or not
there are differences be-
tween men andwo-men.
What is known is that
women metabolize the




which is extremely im-
portant and saving lives
but we may be blasting
women with higher
doses than we need to"
(Gender-AIDS 468).
The differences in vi-
ral loads between men
and women make inter-
preting guidelines for
the onset of anti re-
troviral therapydifficult.
For example, a women
with a co4+ count of
475 and a viral load of
6000 copies/ml IS
roughly at the same risk
ofdisease progression as
a man with a similar
co4+count but with a
viral load of1 0,000 cop-
ies/ml. Guidelines sug-
gest that the man consider anti-HIv
therapy but that the women wait
until her viral load is greater, even
though she is at the same risk of
disease progression as the man.
Present knowledge would suggest
that the drugs are equally effective in
women and in men. However, drugs
may be more toxic in women.
Women tend to show more side ef-
fects or have more severe side effects
than men do. For example, women
are more likely to develop a severe
rash as a side effect of Nevirapine
than men are and drug levels in the
blood are higher in women
(Mary.Elizabeth@aegis.com).
It is obvious that more informa-
tion is needed to understand both
the difference in viral load in men
and women and what this difference
actually means (Project Inform 1999;
2000).
Differences in Opportunistic
Infections, Cancers and Symp-
toms
More research is needed to deter-
mine the different patterns in health
care and treatment issues between
men and women. Gender differences
have been noted in certain infections
associated with HIV disease. This may
include more frequent candidasis
(vaginal, esophageal and oral thrush),
herpes infection and types of cy-
tomegalovirus (CMV) disease
Qohnson and Currier). It is unclear
as to whether these differences are
biologically based or due to psycho-
social issues and treatment access.
Anderson notes that gynecological
problems are common among
women living with HIV/AIDS and are
often present at the time of initial
presentation for care and evaluation.
It is known HIV impacts on hormo-
nal levels and functioning. For ex-
ample, abnormal menstrual cycles,
weight loss, gynecological infections,
headaches, and fatigue in women
may be related to decreasing estrogen
levels. Although hrmone replacement
therapies (HRT) are being used in
both men and women living with
HIV/AIDS in symptom management
and weight maintenance, forwomen
much of the focus is on the use of
hormone therapy as a form birth
control that may not be the central
issue for women.
HIV and Menstrual Complica-
tions
Many HIV-positive women report
changes in their menstrual cycle, in-
cluding longer, shorter, heavier, ir-
regular, or painful periods. Many
doctors, however, view abnormal
menstrual cycles as an inconvenience
rather than a serious medical condi-
tion, and thus do not address them
aggressively, for example with HRT,
which may lead to longer survival.
Problems with menstrual bleeding
can cause or can be a symptom of
anemia; it is thus vital to monitor
menstrual cycles regularly.
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A large study has revealed a signifi-
cantly high prevalence of low-grade
cervical dysplasia in HIv-positive
women (Project Inform 1998). Cer-
vical dysplasia is characterized by
abnormal growth or alteration of
cells on the cervix. In some cases this
may lead to cancer of the cervix. It is
also important to note that pap smears
performed on Hlv-positive women
are more likely to give false negative
results than those given to Hlv-nega-
tive women. There is a strong moti-
vation that sophisticated tests-such
as the use of colposcopy-be advo-
cated for women living with HIV. At
the very least, women living with HIV
should have a pap smear every six
months. Women with abnormal pap
smears should be tested even more
frequently. In South Africa women
have access to four free pap smears in
their lifetime. This is not sufficient
for women living with HIV.
Pelvic Inflammatory Disease (PID)
represents a range of inflammatory
disorders of the upper genital tract
which include fallopian tubes, uterus,
ovaries, and in advanced stages, ab-
dominal lining. PID appears to be
more prevalent, severe, and resistant
to treatment in women living with
HIV/AIDS. Furthermore, studies indi-
cate that the relapse of PID occurs
more in women with compromised
immune systems (Project Inform
1998; 1999). The CDC recommends
hospitalization ofwomen with PID as
intravenous antibiotics should be
administered.
Conclusion
Despite women having been vul-
nerable to HIV infection from the
onset of the epidemic and now con-
stituting over 40 per cent ofall infec-
tions globally, and over 50 per cent
in sub-saharan Africa (UNAIDS), rela-
tively little is known about gender
differences in the ways in which HIV/
AIDS manifests. The focus globally
has been on the prevention ofmother-
to-child rransmission, which for
many is seen as a treatment issue for
women, but in reality is aprevention
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issue. There is a critical need for
more research that focuses onwomen
living with HIV/AIDS to improve the
treatment and prevention of oppor-
tunistic infections as well as the tim-
ing and dosages of anti-retroviral
therapies.
Vicci Tallis is a gender and HIV/AIDS
activist in South Africa. She has been
involved in HIV/AIDS work since 1986.
She is currently involved in a global
study addressing the integration ofgen-
der at an international, national and
local level in response to HIV/AIDS and
its impact on women svulnerability.
I Viral load refers to the amount of
HIV present in the blood. Anti-viral
treatments can bring the viral load
down from tens of thousands to al-
most undetectable levels.
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